Anti-MMP2 antibody [EPR17003-25]
- RabMAb
- Recombinant
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(54 Publications)
Rabbit Recombinant Monoclonal MMP2 antibody. Suitable for IP, WB and reacts with Human, Mouse, Rat samples. Cited in 54 publications.
View Alternative Names
CLG4A, MMP2, 72 kDa type IV collagenase, 72 kDa gelatinase, Gelatinase A, Matrix metalloproteinase-2, TBE-1, MMP-2
- IP
Unknown
Immunoprecipitation - Anti-MMP2 antibody [EPR17003-25] (AB181286)
MMP2 was immunoprecipitated from 0.35 mg HT1080 (human fibrosarcoma cell line) whole cell lysate with ab181286 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab181286 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.
Lane 1 : HT1080 whole cell lysate 10 μg (Input).
Lane 2 : ab181286 IP in HT1080 whole cell lysate (+).
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab181286 in HT1080 whole cell lysate (-).
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 minutes.
All lanes:
Immunoprecipitation - Anti-MMP2 antibody [EPR17003-25] (ab181286)
Predicted band size: 73 kDa
false
- WB
Supplier Data
Western blot - Anti-MMP2 antibody [EPR17003-25] (AB181286)
Exposure time : Lanes 1-2 : 3 minutes; Lanes 3-5 : 10 seconds; Lanes 6-7 : 30 seconds.
Blocking/Dilution buffer : 5% NFDM/TBST.
Lanes 1 - 5:
Western blot - Anti-MMP2 antibody [EPR17003-25] (ab181286) at 1/1000 dilution
Lanes 6 - 7:
Western blot - Anti-MMP2 antibody [EPR17003-25] (ab181286) at 1/2000 dilution
Lane 1:
Mouse plasma lysate at 20 µg
Lane 2:
Rat serum lysate at 20 µg
Lane 3:
Mouse lung lysate at 20 µg
Lane 4:
Rat plasma lysate at 20 µg
Lane 5:
Rat lung lysate at 20 µg
Lane 6:
HT1080 (human fibrosarcoma cell line) whole cell lysate at 10 µg
Lane 7:
Human plasma lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG Peroxidase Conjugate, specific to the non-reduced form of IgG at 1/10000 dilution
Predicted band size: 73 kDa
Observed band size: 72 kDa
false
- WB
Lab
Western blot - Anti-MMP2 antibody [EPR17003-25] (AB181286)
Blocking and diluting buffer and concentration : 5% NFDM /TBST. ab181602 was used as GAPDH loading control. Compared with ab92536, ab181286 has higher sensitivity. We recommend ab181286 as an alternative for testing MMP2 in western blot.
Lanes 1 - 5:
Western blot - Anti-MMP2 antibody [EPR1184] (<a href='/en-us/products/primary-antibodies/mmp2-antibody-epr1184-ab92536'>ab92536</a>) at 1/1000 dilution
Lanes 1 - 5:
Western blot - Anti-MMP2 antibody [EPR17003-25] (ab181286)
Lane 1:
HT-1080 (Human fibrosarcoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
Untreated HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3:
HepG2 (Human hepatocellular carcinoma epithelial cell) treated with 300ng/ml BFA for 24 hours whole cell lysate at 20 µg
Lane 4:
Huh7 (Human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 5:
U-87 MG (Human glioblastoma-astrocytoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 73 kDa
false
Exposure time: 60s
- WB
Lab
Western blot - Anti-MMP2 antibody [EPR17003-25] (AB181286)
Blocking and diluting buffer and concentration : 5% NFDM/TBST. ab181602 was used as a GAPDH loading control. Compared with ab92536, ab181286 has higher sensitivity. We recommend ab181286 as an alternative for testing MMP2 in western blot.
Lanes 1 - 3:
Western blot - Anti-MMP2 antibody [EPR1184] (<a href='/en-us/products/primary-antibodies/mmp2-antibody-epr1184-ab92536'>ab92536</a>) at 1/1000 dilution
Lanes 1 - 3:
Western blot - Anti-MMP2 antibody [EPR17003-25] (ab181286)
Lane 1:
Human plasma tissue lysate at 20 µg
Lane 2:
Human brain tissue lysate at 20 µg
Lane 3:
Human breast tissue lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 73 kDa
Observed band size: 69 kDa,72 kDa
false
Exposure time: 60s
Related conjugates and formulations (2)
-
Anti-MMP2 antibody [EPR17003-25] - BSA and Azide free (Capture)
-
Anti-MMP2 antibody [EPR17003-25] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Matrix metalloproteinase-2 is mainly involved in the degradation of type IV and V collagens gelatin and fibronectin. As part of the metalloproteinase family it works alongside other MMPs to maintain tissue homeostasis and repair. MMP-2 forms part of a complex network that ensures the timely degradation of matrix components balancing synthesis and breakdown. It remains regulated by tissue inhibitors of metalloproteinases (TIMPs) preventing excessive degradation that could lead to tissue damage.
Pathways
MMP-2 plays a significant role within the extracellular matrix (ECM) remodeling and angiogenesis pathways. It interacts with various proteins including integrins and TIMP-2 to modulate cellular behaviors such as migration and invasion. MMP-2 contributes to processes like wound healing and embryonic development through its involvement in ECM degradation and new tissue formation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (54)
Recent publications for all applications. Explore the full list and refine your search
Balkan medical journal 42:440-451 PubMed40888349
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:16205 PubMed40346122
2025
Applications
Unspecified application
Species
Unspecified reactive species
Advanced biology 9:e2400564 PubMed40128149
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in physiology 16:1547661 PubMed40110183
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biomarkers in medicine 18:1103-1111 PubMed39589905
2024
Applications
Unspecified application
Species
Unspecified reactive species
Discover oncology 15:677 PubMed39560824
2024
Applications
Unspecified application
Species
Unspecified reactive species
Chemical biology & drug design 104:e70012 PubMed39487106
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cells 13: PubMed39451222
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of biochemical and molecular toxicology 38:e70011 PubMed39400940
2024
Applications
Unspecified application
Species
Unspecified reactive species
Oncology research 32:1209-1219 PubMed38948021
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com